Expeditious and convenient synthesis of pregnanes and its glycosides as potential anti-dyslipidemic and anti-oxidant agents

被引:18
作者
Sethi, Arun [1 ]
Maurya, Atul
Tewari, Vibha
Srivastava, Sanjay
Faridi, Shaheen
Bhatia, Gitika
Khan, M. M.
Khanna, A. K.
Saxena, J. K.
机构
[1] Univ Lucknow, Dept Chem, Lucknow 226007, Uttar Pradesh, India
[2] Cent Drug Res Inst, Div Biochem, Lucknow 226001, Uttar Pradesh, India
[3] Inst Engn & Technol, Dept Appl Sci, Lucknow, Uttar Pradesh, India
关键词
pregnanes; glycosides; oximo ether; anti-dyslipidemic; anti-oxidant;
D O I
10.1016/j.bmc.2007.04.022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of new pregnane derivatives and its glycosides were synthesized in order to find new 'leads' against some important targets. The 3 beta-hydroxy-16 alpha-(2-hydroxy ethoxy) pregn-5-en-20-one (5) was synthesized from 3 beta-hydroxy-5,16-pregnadiene-20-one (2) by adopting general modified procedure using BF3:Et2O as a catalyst. Reduction of 5, with sodium borohydride yielded 3 beta,20 beta-dihydroxy-16 alpha-(2-hydroxy ethoxy) pregn-5-en (7) as the major isolable product. O-alkylation of the C-20-oxime-pregnadiene (9) with 1,5-dibromopentane yielded 20-(O-5-bromopentyl)-oximino-3 beta-hydroxy-pregn-5,16-diene (11). Synthesis of C-16 substituted pregnane glycosides (20) and (21) were accomplished with the imidate method using BF3:Et2O. The synthesis of 4-chlorobenzoate (3) and 2-chlorobenzoate (4), derivatives of 2 were also accomplished. These compounds were evaluated for their anti-dyslipidemic and anti-oxidant activity and amongst them compounds 3 and 7 showed more lipid lowering and anti-oxidant activity. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4520 / 4527
页数:8
相关论文
共 88 条
[1]  
AHSAN AM, 1973, EXPERIENTIA, V29, P788, DOI 10.1007/BF01946285
[2]   IMPAIRED ACTIVATION OF GLUCOSE-OXIDATION AND NADPH SUPPLY IN HUMAN ENDOTHELIAL-CELLS EXPOSED TO H2O2 IN HIGH-GLUCOSE MEDIUM [J].
ASAHINA, T ;
KASHIWAGI, A ;
NISHIO, Y ;
IKEBUCHI, M ;
HARADA, N ;
TANAKA, Y ;
TAKAGI, Y ;
SAEKI, Y ;
KIKKAWA, R ;
SHIGETA, Y .
DIABETES, 1995, 44 (05) :520-526
[3]  
BANEKO K, 1973, PHYTOCHEMISTRY, V12, P509
[4]   Synthesis of nitro esters of prednisolone, new compounds combining pharmacological properties of both glucocorticoids and nitric oxide [J].
Baraldi, PG ;
Romagnoli, R ;
Nuñez, MD ;
Perretti, M ;
Paul-Clark, MJ ;
Ferrario, M ;
Govoni, M ;
Benedini, F ;
Ongini, E .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (03) :711-719
[5]  
BARBIERI C, 1985, EUR J CLIN PHARMACOL, V29, P213
[6]  
BINDOLI A, 1985, PHARMACOL RES COMMUN, V17, P831, DOI 10.1016/0031-6989(85)90041-4
[7]   Molecular interactions of new pregnenedione derivatives [J].
Bratoeff, E ;
Ramírez, E ;
Flores, E ;
Valencia, N ;
Sánchez, M ;
Heuze, I ;
Cabeza, M .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2003, 51 (10) :1132-1136
[8]  
Buccolo G., 1973, CLIN CHEM, V19, P476
[9]   Transition of dehydro-androsterone in progesterone: A simple way for the artifical production of the pregnancy hormones from cholesterol. [J].
Butenandt, A ;
Schmidt-Thome, J .
BERICHTE DER DEUTSCHEN CHEMISCHEN GESELLSCHAFT, 1939, 72 :182-187
[10]   Novel 17 substituted pregnadiene derivatives as 5α-reductase inhibitors and their binding affinity for the androgen receptor [J].
Cabeza, M ;
Flores, E ;
Heuze, I ;
Sánchez, M ;
Bratoeff, E ;
Ramírez, E ;
Francolugo, VA .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2004, 52 (05) :535-539